Buy (-)-(S)-Equol | AUS 131 | SE 5OH|531-95-3|Inhibitors|from supplier chembestbuy.com|Research only

Home

Add Favorites

Search Product

Live Chat

E-mail

Pharmacology

Inhibitors

Receptors

Hedgehog Signaling Pathway

Research Area

Cardiovascular System

Product Type

Vitamin D series compounds

Toxins

　 More +

Browse Alphabetically by Name

ALL	A	B	C	D	E	F
G	H	I	J	K	L	M
N	O	P	Q	R	S	T
U	V	W	X	Y	Z	Others

CL2040 (-)-(S)-Equol | AUS 131 | SE 5OH (531-95-3)

Catalog No.:	CL2040
CAS No.:	531-95-3
Synonym:	4',7-Isoflavandiol
Chemical Name:	3,4-Dihydro-3-(4-hydroxyphenyl)-2H-1-benzopyran-7-ol, 4’,7-Dihydroxyisoflavane
Molecular Formula:	C₁₅H₁₄O₃
Molecular Weight:	242.3

Technical Data:

Appearance:	Off white or pale yellow solid
Solubility:	Soluble in DMSO and Methanol
Purity:	>98%
Storage:	at -20℃ 2 years
Original QC Data:
Shipping Conditions:	Ambient Temp.

Price and Availability of (-)-(S)-Equol | AUS 131 | SE 5OH:

Size	Price	Stock
50 mg	USD 186	In Stock
100 mg	USD 318	In Stock
250 mg	USD 528	In Stock
500 mg	USD 766	In Stock
1 g	USD 1268	In Stock

Biological Activity:

Equol is a non-steroidal estrogen produced from the metabolism of the isoflavonoid phytoestrogen daidzen by human intestinal microflora. The estrogen receptor (ER) agonist activity of the naturally occurring (S)-enantiomer (EC50 = 85 and 65 nM for human ERα and ERβ, respectively) is similar to that of genistein but exceeds that of daidzein. (S)-Equol preferentially binds ERβ (Ki = 0.73 nM) and demonstrates approximately 9-fold lower affinity for ERα (Ki = 6.41 nM). (S)-equol is also a potent antagonist of dihydrotestosterone, which has important implications for prostate cancer and other androgen-mediated pathologies.

References:

1.Muthyala RS, et al. Bioorg Med Chem, 2004, 12(6), 1559-1567.

2. Setchell KD, et al. J Nutr, 2002, 132(12), 3577-3584.

View Related Products by Target:

Vandetanib

Vorinostat(SAHA)

Tozasertib(VX-680)

Lenalidomide(CC-5013)

Sunitinib Malate(Sutent)